- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06190431
Does the Coaching Function Improve the Learning of Mechanical In-exsufflation (MI-E) in Paediatric Subjects? (MI-Ecoaching)
Study Overview
Status
Detailed Description
RATIONALE In the first part, the population will be composed of healthy children, in the second part, the investigators will include children with neuromuscular diseases. The two parts will follow the same process. The hypothesis is that the use of a coaching module (playful visual stimulation) in addition to guidance by a physiotherapist improves the learning and effectiveness of the MI-E compared to guidance alone. The MI-E technique does not represent any documented risk in its use nor in its indication if the contraindications are respected (non-drained pneumothorax, hemoptysis and hemodynamic instability). Coaching modules (playful visual stimulation) have recently become available on MI-E devices. This experiment will allow us to judge their usefulness in teaching the use of MI-E in paediatric patients.
OBJECTIVES The aim of this study is to test whether the use of a coaching module (playful visual stimulation) in addition to guidance by a physiotherapist improves the learning and effectiveness of the technique compared to guidance alone. This randomized controlled study will first include healthy children, aged 6 to 12 years. In a second phase, the investigators will test the use in children with neuromuscular diseases. For the process (common for the two parts), eligible subjects will be invited to perform, depending on randomization at the intervention 1 (physiotherapist guidance + coaching module) or the intervention 2 (physiotherapist guidance). The learning times, the coughing expiratory flow rate achieved and the synchronization between the subject and the machine will be compared between the two processes.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nicolas Audag, PhD
- Phone Number: 027641621
- Email: nicolas.audag@saintluc.uclouvain.be
Study Contact Backup
- Name: Gregory Reychler, Pr
- Phone Number: 027642316
- Email: gregory.reychler@saintluc.uclouvain.be
Study Locations
-
-
-
Brussels, Belgium, 1200
- Recruiting
- Cliniques Universitaires Saint Luc
-
Contact:
- Nicolas Audag, Phd
- Phone Number: 00327641621
- Email: nicolas.audag@saintluc.uclouvain.be
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Part 1:
Inclusion criteria
- Age 6-12 (F/M)
- Acceptance of consent (child + 2 parents)
- Non-smoker
- Speak and understand French
- Schooling in mainstream education
Exclusion criteria
- Comorbidities: congenital heart disease, chronic lung disease, immune deficiency, neuromuscular disease, neurological disease or multiple disabilities
- History or clinical signs of disease affecting lung function, recent lung infection, spinal or thoracic deformity.
Part 2:
Inclusion criteria
- Age 6-12 (F/M)
- Acceptance of consent (child + 2 parents)
- Non-smoker
- Speak and understand French
- Patient with a neuromuscular disease
- Able to perform the MI-E maneuver
Exclusion criteria
- Hemodynamic instability
- Current or recent pneumothorax
- Hemoptysis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Only physiotherapist guidance
The aim of this study is to test whether the use of a coaching module (playful visual stimulation) in addition to guidance by a physiotherapist improves the learning and effectiveness of the technique compared to guidance alone.
|
Learning to use an in-exsufflation device with the guidance of a physiotherapist
|
Active Comparator: Physiotherapist guidance + coaching module
The aim of this study is to test whether the use of a coaching module (playful visual stimulation) in addition to guidance by a physiotherapist improves the learning and effectiveness of the technique compared to guidance alone.
|
Learning to use an in-exsufflation device with the guidance of a physiotherapist
Learning the use of an in-exsufflation device using a coaching mode (playful visual stimulation) in addition to guidance of a physiotherapist
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effectiveness
Time Frame: A the end of the learning session (after maximum 15 minutes)
|
The investigators will measure the number of sets (n) needed by the subjects to achieve five quality voluntary coughs during the learning session.
|
A the end of the learning session (after maximum 15 minutes)
|
Effectiveness
Time Frame: A the end of the learning (after maximum 15 minutes).
|
The investigators will measure the time needed (sec) by the subjects to achieve five quality voluntary coughs during the learning session.
|
A the end of the learning (after maximum 15 minutes).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Peak cough flow measured with the device (L/min)
Time Frame: During the learning session (max 15 minutes)
|
The peak cough flow reached with the In-exsufflation device will be reported
|
During the learning session (max 15 minutes)
|
Peak cough flow measured with the device (L/min)
Time Frame: During the session on the second day (24 hours after the learning session)
|
The peak cough flow reached with the In-exsufflation device will be reported
|
During the session on the second day (24 hours after the learning session)
|
Visual analog scales (VAS) "ease of use" (0-10)
Time Frame: At the end of the learning session (max 15 minutes)
|
Children will be assessed about the ease of the learning
|
At the end of the learning session (max 15 minutes)
|
Visual analog scales (VAS) "ease of use" (0-10)
Time Frame: At the end of the session on the second day (24 hours after the learning session)
|
Children will be assessed about the ease of the learning
|
At the end of the session on the second day (24 hours after the learning session)
|
Visual analog scales (VAS) "comfort" (0-10)
Time Frame: At the end of the learning session (max 15 minutes)
|
Children will be assessed about the comfort of the procedure
|
At the end of the learning session (max 15 minutes)
|
Visual analog scales (VAS) "comfort" (0-10)
Time Frame: At the end of the session on the second day (24 hours after the learning session)
|
Children will be assessed about the comfort of the procedure
|
At the end of the session on the second day (24 hours after the learning session)
|
the number of sets (n)
Time Frame: At the end of the session on the second day (24 hours after the learning session)
|
The investigators will measure the number of sets (n) needed by the subjects to achieve five Quality voluntary coughs one day after the first session.
|
At the end of the session on the second day (24 hours after the learning session)
|
the time (sec) needed by the subjects to achieve five Quality voluntary coughs
Time Frame: At the end of the session on the second day (24 hours after the learning session)
|
The investigators will measure the time (sec) needed by the subjects to achieve five Quality voluntary coughs one day after the learning session.
|
At the end of the session on the second day (24 hours after the learning session)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Nicolas Audag, PhD, Cliniques universitaires Saint-Luc
Publications and helpful links
General Publications
- Hull J, Aniapravan R, Chan E, Chatwin M, Forton J, Gallagher J, Gibson N, Gordon J, Hughes I, McCulloch R, Russell RR, Simonds A. British Thoracic Society guideline for respiratory management of children with neuromuscular weakness. Thorax. 2012 Jul;67 Suppl 1:i1-40. doi: 10.1136/thoraxjnl-2012-201964. No abstract available.
- Panitch HB. Respiratory Implications of Pediatric Neuromuscular Disease. Respir Care. 2017 Jun;62(6):826-848. doi: 10.4187/respcare.05250.
- Miske LJ, McDonough JM, Weiner DJ, Panitch HB. Changes in gastric pressure and volume during mechanical in-exsufflation. Pediatr Pulmonol. 2013 Aug;48(8):824-9. doi: 10.1002/ppul.22671. Epub 2012 Sep 4.
- Hov B, Andersen T, Toussaint M, Mikalsen IB, Vollsaeter M, Markussen H, Indrekvam S, Hovland V. User-perceived impact of long-term mechanical assisted cough in paediatric neurodisability. Dev Med Child Neurol. 2023 May;65(5):655-663. doi: 10.1111/dmcn.15543. Epub 2023 Feb 14.
- Hov B, Andersen T, Toussaint M, Vollsaeter M, Mikalsen IB, Indrekvam S, Hovland V. Prevalence of long-term mechanical insufflation-exsufflation in children with neurological conditions: a population-based study. Dev Med Child Neurol. 2021 May;63(5):537-544. doi: 10.1111/dmcn.14797. Epub 2021 Jan 3.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MI-E coaching project
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neuromuscular Diseases
-
Brugmann University HospitalCompletedAnesthesia, General | Neuromuscular Transmission DisordersBelgium
-
University Hospital, ToursCompletedNeuromuscular Diseases in Children | Neuromuscular Diseases in InfantsFrance
-
Ottawa Hospital Research InstituteRecruiting
-
University of FloridaTerminated
-
Penwest Pharmaceuticals Co.TerminatedNeuromuscular DiseaseUnited Kingdom
-
Linde AGCompletedFunctional Test, COPD, Neuromuscular Disorders, Mechanical Ventilation, Weaning, DisabilityArgentina, Colombia, Germany
-
Centre d'Investigation Clinique et Technologique...Association Française contre les Myopathies (AFM), ParisCompletedCommunication | Neuromuscular DiseaseFrance
-
National Institute of Nursing Research (NINR)TerminatedNeuromuscular DiseaseUnited States
-
Landon Pediatric FoundationCompleted
Clinical Trials on Learning the use of an in-exsufflation device with the guidance of a physiotherapist
-
University of RzeszowDonum Corde Rehabilitation CenterNot yet recruitingNervous System Diseases | Physical Activity | Neurorehabilitation | Biomedical Enhancement
-
OsteovoxUnknownTemporomandibular DisorderBelgium, France, Italy
-
Pluromed, Inc.CompletedRenal Calculi | Kidney StonesCanada
-
University Hospital, Clermont-FerrandUniversité d'Auvergne; Tza Nou - Maison médicale pour enfants et adolescentes... and other collaboratorsCompleted
-
Centre hospitalier de l'Université de Montréal...Completed
-
Istituto Clinico HumanitasRecruiting
-
Centre Hospitalier Universitaire de NīmesCompleted
-
Memorial Sloan Kettering Cancer CenterTerminatedFibrillation | Post-Operative Cancer Patients Experiencing AtrialUnited States
-
University of AlicanteCompletedCardiovascular Diseases | Hypertension | Exercise | Body Composition | Overweight and Obesity | Machine Learning | Diet, Mediterranean | Triglyceride-Storage; DiseaseSpain
-
Hospices Civils de LyonTerminatedPatients Intubated in ICU Before ExtubationFrance